Company Filing History:
3 out of 3,540 
3 out of 4 Years Active: 2018-2022
Title: Innovations by Marina Bok in Norovirus Research
Introduction
Marina Bok is an accomplished inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of virology, particularly in the development of monoclonal antibodies targeting noroviruses. With a total of three patents to her name, her work has the potential to impact public health significantly.
Latest Patents
Marina Bok's latest patents include "Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use." This patent discloses isolated VH monoclonal antibodies that specifically bind to a Norovirus polypeptide. The Norovirus can be a Genogroup I or Genogroup II Norovirus, including strains such as Norwalk or MD2004 virus. The monoclonal antibodies specifically bind to the VP1 protein. Additionally, the patents describe compositions that include these antibodies, nucleic acids encoding them, expression vectors, and isolated host cells that express the nucleic acids. These antibodies and compositions can be utilized for detecting the presence of a Norovirus in biological samples or for diagnosing a Norovirus infection. Furthermore, methods for treating and preventing Norovirus infections are also disclosed.
Career Highlights
Throughout her career, Marina Bok has worked with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the Instituto Nacional de Tecnología